23 results
8-K
EX-1.1
ACXP
Acurx Pharmaceuticals Inc
17 May 23
Acurx Pharmaceuticals, Inc. Announces Pricing of $4.0 Million Registered Direct Offering
4:19pm
no duties or liabilities to the equity holders or the creditors of the Company or any other person by virtue of this Agreement or the retention
PRE 14A
gmg lcp7y
17 Apr 23
Preliminary proxy
4:05pm
8-K
EX-1.1
pjv3kkl
25 Jul 22
Acurx Pharmaceuticals, Inc. Announces $4.225 Million Registered Direct Offering
8:46am
DEF 14A
w668eo
25 Apr 22
Definitive proxy
4:06pm
S-8
EX-99.4
24k2n8 mn6khe
19 Jul 21
Registration of securities for employees
5:27pm
424B4
bmjmxc molqiprjg
28 Jun 21
Prospectus supplement with pricing info
6:02am
S-1/A
mubv43
11 Jun 21
IPO registration (amended)
6:02am
S-1
i4zkf
27 May 21
IPO registration
12:00am
S-1
EX-10.1
3lb1dpjo
27 May 21
IPO registration
12:00am
S-1
EX-10.10
n5dh1cq57jqzidmi1
27 May 21
IPO registration
12:00am
S-1
EX-10.2
cpw4cgw
27 May 21
IPO registration
12:00am
S-1
EX-10.11
gpuyulzd3 y8rv8f7
27 May 21
IPO registration
12:00am
S-1
EX-10.9
hp2q2 tf8ybg06dwu8ns
27 May 21
IPO registration
12:00am
DRS/A
EX-10.10
9t4qg9ry f5cb4
10 May 21
Draft registration statement (amended)
12:00am
DRS/A
EX-10.11
xwu4nbmto
10 May 21
Draft registration statement (amended)
12:00am
DRS/A
tp1ltpf2opsg
10 May 21
Draft registration statement (amended)
12:00am